US equities
|
INTC
$64.97
▼-29.44%
AMZN
$240.47
▼-1.36%
NVDA
$204.80
▼-4.15%
MU
$884.53
▼-5.32%
GOOGL
$280.51
▼-1.17%
SNDK
$1,169.44
▼-12.08%
AMD
$503.75
▼-11.06%
SPCX
$138.07
▼-4.04%
INTC
$64.97
▼-29.44%
AMZN
$240.47
▼-1.36%
NVDA
$204.80
▼-4.15%
MU
$884.53
▼-5.32%
GOOGL
$280.51
▼-1.17%
SNDK
$1,169.44
▼-12.08%
AMD
$503.75
▼-11.06%
SPCX
$138.07
▼-4.04%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about #covid/19
Recent news which mentions #covid/19
The Path to Job Mobility
February 11, 2022
Tickers
MA
Tags
future of work
#covid/19
Brookings Institution
From
3BL Media: Corporate Social Responsibility, Energy and Health News
Merck and Ridgeback Announce Publication of Phase 3 Study of Molnupiravir, an Investigational Oral Antiviral COVID-19 Treatment, in the New England Journal of Medicine
December 17, 2021
Tickers
MRK
Tags
#covid/19
Merck & Co
Health & Healthcare
From
3BL Media: Corporate Social Responsibility, Energy and Health News